Dr. Paul Singh, MD
Claim this profileEye Centers of Racine and Kenosha
Studies Cataract
Studies Glaucoma
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Paul Singh, MD is currently running
More about Paul Singh, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical TrialTreatments Paul Singh, MD has experience with
- Triamcinolone Acetonide
- IStent Inject W
- Streamline Surgical System
Breakdown of trials Paul Singh, MD has run
Primary Open Angle Glaucoma
Open-Angle Glaucoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Singh, MD specialize in?
Paul Singh, MD focuses on Cataract and Glaucoma. In particular, much of their work with Cataract has involved treating patients, or patients who are undergoing treatment.
Is Paul Singh, MD currently recruiting for clinical trials?
Yes, Paul Singh, MD is currently recruiting for 1 clinical trial in Racine Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Paul Singh, MD has studied deeply?
Yes, Paul Singh, MD has studied treatments such as Triamcinolone Acetonide, iStent Inject W, Streamline Surgical System.
What is the best way to schedule an appointment with Paul Singh, MD?
Apply for one of the trials that Paul Singh, MD is conducting.
What is the office address of Paul Singh, MD?
The office of Paul Singh, MD is located at: Eye Centers of Racine and Kenosha, Racine, Wisconsin 53405 United States. This is the address for their practice at the Eye Centers of Racine and Kenosha.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.